paclitaxel has been researched along with Island Cell Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farshori, PQ; Goode, D | 1 |
| Ansell, SM; Burch, PA; Kvols, LK; Mahoney, MR; Pitot, HC; Rubin, J | 1 |
1 trial(s) available for paclitaxel and Island Cell Tumor
| Article | Year |
|---|---|
A Phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors.
Topics: Adenoma, Islet Cell; Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoid Tumor; Disease Progression; Disease-Free Survival; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Male; Middle Aged; Neutropenia; Paclitaxel; Pancreatic Neoplasms; Treatment Outcome | 2001 |
1 other study(ies) available for paclitaxel and Island Cell Tumor
| Article | Year |
|---|---|
Effects of the microtubule depolymerizing and stabilizing agents Nocodazole and taxol on glucose-induced insulin secretion from hamster islet tumor (HIT) cells.
Topics: Adenoma, Islet Cell; Animals; Colforsin; Cricetinae; Fluorescent Antibody Technique; Glucose; Insulin; Insulin Secretion; Microscopy, Electron; Microtubules; Nocodazole; Paclitaxel; Pancreatic Neoplasms; Tumor Cells, Cultured | 1994 |